Dad quits top firm to help people like his young son survive

Capsules

His 2-year-old son’s life may depend on his success.

Ilan Ganot, a hedge fund professional at JPMorgan Chase, left his life in finance to create a new business model aimed at developing drugs more quickly. His son’s life may depend on his success.

Bloomberg News reports that since his 2-year-old was diagnosed a year ago with Duchenne muscular dystrophy, a fatal genetic disease, Ganot quit his job in London, moved his family to the Boston area, raised $17 million and founded a biotechnology company.

Ganot, 40, a former Israeli army captain, is one of a generation of parents who are stepping in when medicine and industry don’t move fast enough to save their children. Instead of the usual approach of forming or supporting an advocacy group, Ganot is using his roots in finance to start a business aimed at getting treatments to market.

'He’s a really exceptional example of a parent who says, ‘I’m going to take my skills and apply them to this problem,’' said Sharon Hesterlee, vice president of research at Parent Project Muscular Dystrophy, a nonprofit focused on the disease. 'You want them to solve world peace after this'.

Hit the link below to access the complete Bloomberg article:

JPMorgan Dad Starts Biotech in Muscular Dystrophy Quest

BofA Said to Boost CEO’s Compensation 17% to $14 Million

 

Bank Workers CharityBank Workers Charity - Supporting bank workers

Register for Financial Markets News Alerts